Davita (NYSE:DVA) hit a new 52-week high Wednesday as it changed hands at $79.71 compared with its previous 52-week high of $79.70. Davita is currently trading at $79.67 with 14,117 shares changing hands as of 9:35 a.m..
NEW YORK ( TheStreet) -- Davita (NYSE: DVA) hit a new 52-week high Wednesday as it traded at $79.71 compared with its previous 52-Week high of $79.70. Davita is changing hands at $79.67 with 14,117 shares traded as of 9:35 a.m. ET. Average volume has been 782,600 shares over the past 30 days. Davita has a market cap of $7.6 billion and is part of the health care sector and health services industry. Shares are up 13.8% year to date as of the close of trading on Tuesday. DaVita Inc. provides dialysis services for patients suffering from chronic kidney failure, which is known as end stage renal disease (ESRD) in the United States. The company has a P/E ratio of 17.9, below the average health services industry P/E ratio of 19.9 and below the S&P 500 P/E ratio of 23.4. TheStreet Ratings rates Davita as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity and solid stock price performance. We feel these strengths outweigh the fact that the company shows weak operating cash flow. You can view the full Davita Ratings Report. See all 52-week high stocks or get investment ideas from our investment research center.